株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のドラッグデリバリーシステム市場

Global Pharmaceutical Drug Delivery System Market 2019 - 2025

発行 Orion Market Research Pvt Ltd 商品コード 911639
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
世界のドラッグデリバリーシステム市場 Global Pharmaceutical Drug Delivery System Market 2019 - 2025
出版日: 2019年08月23日 ページ情報: 英文
概要

当レポートは世界のドラッグデリバリーシステム市場について調査しており、市場機会、成長および阻害要因、投与経路・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法およびツール
  • 市場分析
    • セグメント別
    • 地域別
    • 利害関係者別

第2章 市場の概要および洞察

  • レポートの範囲
  • アナリストの洞察および現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則および規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • GlaxoSmithKline PLC
    • AstraZeneca PLC
    • Boehringer Ingelheim International GmbH
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメント

  • 投与経路別
    • 注射
    • 局所
    • 経肺
    • 経鼻
    • その他(経眼)
  • 用途別
    • 感染症
    • 心血管疾患(CVD)
    • 糖尿病
    • 神経系障害
    • 呼吸器疾患
    • その他(自己免疫疾患)
  • エンドユーザー別
    • 病院および診療所
    • 外来手術センター(ASC)
    • ホームケア
    • 診断センター

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • 3B Medical Inc.
  • 3M Co.
  • Acorda Therapeutics Inc.
  • Amgen Inc.
  • Antares Pharma, Inc.
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Bayer AG
  • Becton, Dickinson and Co.
  • BMC Medical Co. Ltd.
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Invacare Corp.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • オムロン ヘルスケア株式会社
  • Pfizer, Inc.
  • PMD Device Solutions Ltd.
  • ProMed Pharma LLC
  • ResMed Inc.
  • Sanofi SA
  • Teicos Pharma, Ltd.
図表

List of Tables

  • 1. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL INJECTABLE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL TOPICAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL PULMONARY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL NASAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OTHER ROUTES FOR PHARMACEUTICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 8. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR CVD MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR NERVOUS SYSTEM DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 16. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 18. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 19. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 20. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 22. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
  • 23. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 24. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 25. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 26. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
  • 1. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 2. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 3. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 4. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
  • 5. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 6. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 7. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
  • 8. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 9. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (%)
  • 2. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 4. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019857

Title:
Global Pharmaceutical Drug Delivery System
Market Size, Share & Trends Analysis Report by Route of Administration (Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, and Others), by Application (Infectious Diseases, Cancer, Cardiovascular Diseases (CVDs), Diabetes, Nervous System Disorders, Respiratory Diseases, and Others), by End-User (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), Homecare, and Diagnostic Centers) and Forecasts, 2019 - 2025.

The global pharmaceutical drug delivery system market is expected to register significant growth over the forecast period. The growth of the market is primarily driven by the rising prevalence of chronic diseases. Moreover, growth in the biologics market coupled with technological advancements and new product launch is also augmenting the market growth in recent years. The global pharmaceutical drug delivery system market is segmented on the basis of the route of administration, application, end-user, and region.

The market, on the basis of route of administration, is further segmented into injectable drug delivery, topical drug delivery, pulmonary drug delivery, nasal drug delivery, and others. Among these, topical drug delivery offers various advantages such as convenience and ease of use, painless and noninvasive delivery, and enhanced patient compliance. Further, on the basis of application, the market is segmented into infectious diseases, cancer, CVDs, diabetes, nervous system disorders, respiratory diseases, and others. On the basis of end-user, the market is segmented into hospitals and clinics, ASCs, homecare, and diagnostic centers. Among these, pharmaceutical drug delivery in hospitals and clinics market is expected to contribute significantly due to an increase in the number of inpatient and outpatient visits to hospitals for the treatment of various chronic diseases.

Geographically, the report analyzes the market into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have the largest market size in the global pharmaceutical drug delivery system market. The market growth is attributed to the presence of a large number of prominent players such as 3M Co., Boston Scientific Corp., and Becton Dickinson and Co. In addition, the region has well-established healthcare infrastructure, which further gives a boost to the growth of the market in North America. Moreover, Asia-Pacific is expected to exhibit a considerable growth rate during the forecast period. The market growth is attributed to increasing population pool with aged people coupled with the rise in prevalence of chronic diseases.

The global pharmaceutical drug delivery system market consists of several players operating in the market. Some of the players in the market include Johnson & Johnson, F. Hoffman-La Roche Ltd., Merck KGaA, Bayer AG, Pfizer, Inc., Novartis AG, GlaxoSmithKline PLC, 3M Co., Becton, Dickinson and Co., and Antares Pharma, Inc., among others. Novartis AG is one of the leading players in the global pharmaceutical drug delivery system market. The company adopts several organic and inorganic growth strategies, such as partnerships and collaborations and new product launches to maintain its leading position in the market. For instance, in 2018, Novartis established a partnership with Gan & Lee (China) for the commercialization and supply of biosimilar versions of insulins (glargine, lispro, and aspart), used in patients with type 1 and type 2 diabetes. With this partnership, the company is aimed at strengthening its customer base in different geographical regions.

Research Methodology

The market study of the global pharmaceutical drug delivery system market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authenticate databases such as the National Institute of Health, American Heart Association, and others.
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceutical companies, medical device manufacturers, healthcare providers, academic and research institutes, potential start-ups, investors and venture capitalists, and government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

  • 1. Global Pharmaceutical Drug Delivery System Market Research and Analysis by Route of Administration
  • 2. Global Pharmaceutical Drug Delivery System Market Research and Analysis by Application
  • 3. Global Pharmaceutical Drug Delivery System Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global pharmaceutical drug delivery system market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global pharmaceutical drug delivery system market.
  • Insights about market determinants which are stimulating the global pharmaceutical drug delivery system market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. GlaxoSmithKline PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. Swot Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. AstraZeneca PLC
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. Swot Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boehringer Ingelheim International GmbH
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. Swot Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bayer AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. Swot Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. F. Hoffmann-La Roche Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. Swot Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Pharmaceutical Drug Delivery System Market by Route of Administration
    • 5.1.1. Injectable Drug Delivery
    • 5.1.2. Topical Drug Delivery
    • 5.1.3. Pulmonary Drug Delivery
    • 5.1.4. Nasal Drug Delivery
    • 5.1.5. Others (Ocular Drug Delivery)
  • 5.2. Global Pharmaceutical Drug Delivery System Market by Application
    • 5.2.1. Infectious Diseases
    • 5.2.2. Cancer
    • 5.2.3. Cardiovascular Diseases (CVDs)
    • 5.2.4. Diabetes
    • 5.2.5. Nervous System Disorders
    • 5.2.6. Respiratory Diseases
    • 5.2.7. Others (Autoimmune Disorders)
  • 5.3. Global Pharmaceutical Drug Delivery System Market by End-User
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Ambulatory Surgery Centers (ASCs)
    • 5.3.3. Homecare
    • 5.3.4. Diagnostic Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3B Medical Inc.
  • 7.2. 3M Co.
  • 7.3. Acorda Therapeutics Inc.
  • 7.4. Amgen Inc.
  • 7.5. Antares Pharma, Inc.
  • 7.6. AstraZeneca PLC
  • 7.7. Baxter International, Inc.
  • 7.8. Bayer AG
  • 7.9. Becton, Dickinson and Co.
  • 7.10. BMC Medical Co. Ltd.
  • 7.11. Boehringer Ingelheim International GmbH
  • 7.12. Boston Scientific Corp.
  • 7.13. F. Hoffmann-La Roche Ltd.
  • 7.14. GlaxoSmithKline PLC
  • 7.15. Invacare Corp.
  • 7.16. Johnson & Johnson
  • 7.17. Koninklijke Philips N.V.
  • 7.18. Medtronic PLC
  • 7.19. Merck KGaA
  • 7.20. Mylan N.V.
  • 7.21. Novartis AG
  • 7.22. Omron Healthcare Inc.
  • 7.23. Pfizer, Inc.
  • 7.24. PMD Device Solutions Ltd.
  • 7.25. ProMed Pharma LLC
  • 7.26. ResMed Inc.
  • 7.27. Sanofi SA
  • 7.28. Teicos Pharma, Ltd.
Back to Top